Review

The big news this week was an unexpected move by President Biden regarding pardoning federal cannabis offenders and to seek rescheduling talks. BDSA data for August showed a small sequential decline across the 11 markets it covers in total. 2 rose and 9 fell. Illinois released its adult-use sales for September, which had a day less than August but increased 1% sequentially to $130.7 million, up 7.4% from a year ago. Hifyre data for September suggests that Canadian cannabis sales will fall 4.6% sequentially to C$374 million, up just 7.7% from a year ago.

I distributed this written material to 420 Investor subscribers during the week:

• Biden Lifts the Cannabis Market

• Financial Preview for Tilray Brands FY23-Q1

• A Look at Springbig

• 
  

  Cannabis Sub-Sector Review - 09/30/22

• 420 Investor Model Portfolio Composition 09/30/22

• 420 Investor Weekly Review 09/30/22

• 420 Investor Newsletter - Volume 9, Edition 10

Here are some of this week's highlights for Focus List names:

• ACB repurchased about $23 million of convertible notes at a slight discount.
• AYRWF launched HAZE concentrates in Florida.
• CCHWF launched Hedy, a new edibles brand.
• CEAD added a new client in Connecticut obtained through Merida Capital.
• CURLF closed the acquisition of Tryke and will pay out its former owners over the next three years. The company opened another dispensary in Florida and in Arizona.
• CWBHF amended its license agreement with Stanley Brothers and also reached a separation agreement with former CFO and COO Booysen.
• GNLN announced that CEO Kovacevich will step down at the end of the year, with Craig Snyder, now President, becoming the new CEO and Kovacevich remaining on the Board of Directors and taking on a new role as Chief Development Officer.
• GTBIF had three of its independent directors resign and added two new ones. The company partnered with Purple ...

Review

There was no important industry news this week.

I distributed this written material to 420 Investor subscribers during the week:

• Avoid Most Canadian LPs for Now

• Cannabis Sub-Sector Review - 09/23/22

• 420 Investor Model Portfolio Composition 09/23/22

• 420 Investor ...

Review

Canada is finally reviewing the adult-use program. The country saw sales increase sequentially by 4.5% to C$394.8 million in July, up 17.8% from a year ago.

I distributed this written material to 420 Investor subscribers during the week:

• Why ...

Review

Michigan cannabis sales fell 1% sequentially in August due to continued weakness in medical. Sales of $207.9 million, up 26% from a year ago, were supported by a record level of adult-use sales.

I distributed this written material to ...

Review

BDSA data for July showed continued modest growth in most of the states that they track sequentially in July. Mature markets in the West fell dramatically from a year ago. Hifyre data suggests that Canadian retail cannabis sales fell ...

Review

Illinois adult-use cannabis sales fell 5% sequentially in August, rising 6% from a year ago, to $129.4 million.

I distributed this written material to 420 Investor subscribers during the week:

• MSOS Is a Bad Cannabis Bet

  
  

• Preview of Jushi ...

Review

ETFMG is now including MSOs in its MJ ETF. AdvisorShares introduced leverage to its platform for the MSOS ETF. Ohio released data that suggests the state's medical cannabis program is still seeing weekly sales in excess of $9 million. ...

Review

Canadian cannabis sales set a record in June! The StatsCan data showed a 1% sequential increase to C$377.5 million, up 22% from the prior year.

I distributed this written material to 420 Investor subscribers during the week:

• Financial Previews ...

Review

Illinois medical cannabis sales for July were released and left overall sales for the state up 6% from a year ago and just 1.6% sequentially from June. Michigan adult-use flower sales boomed, leaving July sales at a record $210 ...

Review

Illinois adult-use cannabis sales lifted 7% sequentially to $135.7 million, up 6.% from a year earlier. Hifyre July data predicts that the month will be a record for sales in Canada, up 7% sequentially from June.

I distributed this ...

Review

The House passed a medical cannabis research bill that may be also approved by the Senate.

I distributed this written material to 420 Investor subscribers during the week:

• Preview of Tilray Q4 Financials

• 420 Investor Model Portfolio Composition 07/22/22 ...

Review

StatsCan released data that indicated Canadian sales of cannabis in May set a record of C$375.8 million, up a little sequentially and about 20% from a year ago.

I distributed this written material to 420 Investor subscribers during the ...